4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0000950170-24-107527
President & CEO acquired 399,760 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion | +283,846 | 481,397 | D | ||
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion | +115,914 | 398,277 | I | ||
| Derivatives | |||||||
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion · Series A Convertible Preferred Stock | −2,015,681 | 0 | D | ||
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion · Series A Convertible Preferred Stock | −345,705 | 0 | I | ||
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion · Series B Convertible Preferred Stock | −1,396,762 | 0 | D | ||
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion · Series B Convertible Preferred Stock | −76,969 | 0 | I | ||
| Hawryluk P. Kent President & CEO | 2024-09-16 | Conversion · Series C Convertible Preferred Stock | −970,873 | 0 | I | ||
Loading xslF345X05/ownership.xml…